Met Life Investment Management, LLC Ocular Therapeutix, Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 90,280 shares of OCUL stock, worth $767,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,280

Previous 90,280 -0.0%

Holding current value

$767,380

Previous $617,000 27.23%

% of portfolio

0.0%

Previous 0.0%

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.2 - $8.69 $129,977 - $268,929	30,947 Added 52.16%	90,280 $617,000
Q1 2024 May 14, 2024	BUY	$3.85 - $10.93 $228,432 - $648,509	59,333 New	59,333 $539,000
Q2 2023 Apr 29, 2024	BUY	$4.6 - $7.64 $186,980 - $310,550	40,648 New	40,648 $209,000
Q1 2023 May 09, 2024	BUY	$2.79 - $6.27 $113,407 - $254,862	40,648 New	40,648 $214 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $38,437 - $86,381	13,777 Added 51.27%	40,648 $214,000
Q4 2022 May 10, 2024	SELL	$2.61 - $4.41 $36,568 - $61,788	-14,011 Reduced 34.27%	26,871 $75,000
Q4 2022 Jun 14, 2023	SELL	$2.61 - $4.41 $35,957 - $60,756	-13,777 Reduced 33.89%	26,871 $75,000
Q4 2022 Mar 22, 2023	SELL	$2.61 - $4.41 $36,568 - $61,788	-14,011 Reduced 34.27%	26,871 $75,000
Q4 2022 Feb 15, 2023	SELL	$2.61 - $4.41 $36,568 - $61,788	-14,011 Reduced 34.27%	26,871 $75,000
Q3 2022 Jun 14, 2023	BUY	$4.09 - $6.5 $957 - $1,521	234 Added 0.58%	40,882 $169,000
Q2 2022 May 10, 2024	BUY	$3.01 - $5.22 $54,083 - $93,792	17,968 Added 78.41%	40,882 $164,000
Q2 2022 Jun 20, 2023	BUY	$3.01 - $5.22 $704 - $1,221	234 Added 0.58%	40,882 $164,000
Q2 2022 Mar 22, 2023	BUY	$3.01 - $5.22 $54,083 - $93,792	17,968 Added 78.41%	40,882 $164,000
Q2 2022 Aug 11, 2022	BUY	$3.01 - $5.22 $54,083 - $93,792	17,968 Added 78.41%	40,882 $164,000
Q1 2022 May 10, 2024	BUY	$4.83 - $7.35 $110,674 - $168,417	22,914 New	22,914 $113,000
Q1 2022 Jun 20, 2023	SELL	$4.83 - $7.35 $85,655 - $130,344	-17,734 Reduced 43.63%	22,914 $113,000
Q1 2022 Mar 22, 2023	SELL	$4.83 - $7.35 $26,521 - $40,358	-5,491 Reduced 19.33%	22,914 $113,000
Q1 2022 May 12, 2022	SELL	$4.83 - $7.35 $26,521 - $40,358	-5,491 Reduced 19.33%	22,914 $113,000
Q4 2021 May 17, 2024	BUY	$6.16 - $12.07 $50,653 - $99,251	8,223 Added 40.74%	28,405 $197,000
Q4 2021 Jun 21, 2023	SELL	$6.16 - $12.07 $75,416 - $147,773	-12,243 Reduced 30.12%	28,405 $197,000
Q4 2021 Mar 22, 2023	BUY	$6.16 - $12.07 $50,653 - $99,251	8,223 Added 40.74%	28,405 $197,000
Q4 2021 Feb 15, 2022	BUY	$6.16 - $12.07 $50,653 - $99,251	8,223 Added 40.74%	28,405 $198,000
Q3 2021 May 17, 2024	SELL	$9.7 - $14.34 $77,182 - $114,103	-7,957 Reduced 28.28%	20,182 $201,000
Q3 2021 Jun 21, 2023	SELL	$9.7 - $14.34 $198,520 - $293,482	-20,466 Reduced 50.35%	20,182 $201,000
Q3 2021 Mar 22, 2023	SELL	$9.7 - $14.34 $77,182 - $114,103	-7,957 Reduced 28.28%	20,182 $201,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $77,182 - $114,103	-7,957 Reduced 28.28%	20,182 $202,000
Q2 2021 Jun 21, 2023	SELL	$13.43 - $19.16 $167,995 - $239,672	-12,509 Reduced 30.77%	28,139 $399,000
Q1 2021 May 17, 2024	SELL	$15.82 - $22.11 $493,489 - $689,699	-31,194 Reduced 52.57%	28,139 $461,000
Q1 2021 Jun 26, 2023	SELL	$15.82 - $22.11 $197,892 - $276,573	-12,509 Reduced 30.77%	28,139 $462 Million
Q1 2021 Mar 22, 2023	SELL	$15.82 - $22.11 $2,009 - $2,807	-127 Reduced 0.45%	28,139 $461,000
Q1 2021 May 14, 2021	SELL	$15.82 - $22.11 $2,009 - $2,807	-127 Reduced 0.45%	28,139 $462,000
Q4 2020 May 24, 2024	BUY	$7.91 - $22.95 $6,976 - $20,241	882 Added 3.22%	28,266 $585,000
Q4 2020 Jun 22, 2023	SELL	$7.91 - $22.95 $97,941 - $284,166	-12,382 Reduced 30.46%	28,266 $585,000
Q4 2020 Mar 22, 2023	BUY	$7.91 - $22.95 $6,976 - $20,241	882 Added 3.22%	28,266 $585,000
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $6,976 - $20,241	882 Added 3.22%	28,266 $585,000
Q3 2020 May 24, 2024	BUY	$7.36 - $9.87 $47,067 - $63,118	6,395 Added 30.47%	27,384 $208 Million
Q3 2020 Jun 26, 2023	SELL	$7.36 - $9.87 $97,623 - $130,915	-13,264 Reduced 32.63%	27,384 $208,000
Q3 2020 Mar 22, 2023	BUY	$7.36 - $9.87 $47,067 - $63,118	6,395 Added 30.47%	27,384 $208,000
Q3 2020 Nov 13, 2020	BUY	$7.36 - $9.87 $47,067 - $63,118	6,395 Added 30.47%	27,384 $208,000
Q2 2020 May 24, 2024	SELL	$4.67 - $8.95 $179,066 - $343,178	-38,344 Reduced 64.63%	20,989 $175 Million
Q2 2020 Jun 26, 2023	SELL	$4.67 - $8.95 $91,807 - $175,948	-19,659 Reduced 48.36%	20,989 $174,000
Q1 2020 Jul 12, 2023	SELL	$3.95 - $7.4 $77,653 - $145,476	-19,659 Reduced 48.36%	20,989 $103,000
Q1 2020 Mar 22, 2023	SELL	$3.95 - $7.4 $23,233 - $43,526	-5,882 Reduced 21.89%	20,989 $103,000
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $82,906 - $155,318	20,989 New	20,989 $104,000
Q3 2018 Nov 14, 2018	SELL	$5.42 - $6.99 $94,080 - $121,332	-17,358 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$5.99 - $8.17 $103,974 - $141,814	17,358 New	17,358 $117,000

Others Institutions Holding OCUL

# of Institutions

171

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Ocular Therapeutix, Inc Transaction History